Renaissance Technologies’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
DTC
Renaissance Technologies's GH Position: Q2 2026 in Review
Renaissance Technologies sold out of Guardant Health (GH) in Q2 2026, closing a stake of 337,600 shares — an estimated $31.2M sold.
Renaissance Technologies first reported a position in GH in Q3 2019 and held it in 12 quarters. The position peaked at $61.5M in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Renaissance Technologies reported no remaining Guardant Health position as of Q2 2026 after selling out during the quarter.
- Renaissance Technologies sold 337,600 Guardant Health shares in Q2 2026, an estimated $31.2M.
- Renaissance Technologies first reported a position in Guardant Health in Q3 2019 and held it in 12 quarters.
- Renaissance Technologies's Guardant Health position peaked at $61.5M in Q4 2025.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.